LUTATHERA Injection General Use Result Survey
NCT05844332
·
clinicaltrials.gov ↗
COMPLETED
Status
347
Enrollment
INDUSTRY
Sponsor class
Conditions
Somatostatin Receptor-positive Neuroendocrine Tumor
Interventions
OTHER:
LUTATHERA
Sponsor
Novartis Pharmaceuticals